Optimizing the Approach to Anemia in the Preterm Infant: Is There a Role for Erythropoietin Therapy?

Journal of Perinatology

Volumn 17, Issue 4, 1997, Pages 276-282

  Asch, Julie ^a   Wedgwood, Josiah F ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD; BLOOD TRANSFUSION; HUMAN; LOW BIRTH WEIGHT; NEWBORN; PREMATURITY;

ANEMIA; BLOOD TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 0031178549     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Harmening D. Transfusion reactions. Modern blood banking and transfusion practices, 2nd ed. Philadelphia: FA Davis; 1989. p. 235-50.
2. Strauss R, Burmeister L, James T, et al. A randomized trial of fresh versus stored RBCs for neonatal transfusions. Abstract S269. Transfusion 1994; 34 Suppl: 65.
3. Cook S, Gunter J, Wissel M. Effective use of a strategy using assigned red cell units to limit donor exposure for neonatal patients. Transfusion 1993;33:379-83.
4. Pothiawala M, Azeem S. Minimizing donor exposure to infants using consigned units. Abstract 14S. Transfusion 1993; 33 Suppl:75.
5. Lee D, Slagle T, Jackson T, Evans C. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red cells. J Pediatr 1995;126:280-6.
6. Liu E, Mannino F, Lane T. A prospective, randomized, controlled trial of the safety and efficacy of a limited donor exposure transfusion program in premature neonates. Abstract S295. Transfusion 1993;33 Suppl:76.
7. Luban N, Strauss R, Hume H. Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusion. Transfusion 1991;31:229-35.
8. Sacher R, Luban N, Strauss R. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev 1989;3:39-54.
9. Strauss R, Sacher R, Blazina J. Commentary on small volume red cell transfusions for neonatal patients. Transfusion 1990;30:565-70.
10. Strauss R. Transfusion therapy in neonates. Am J Dis Child 1991;145: 904-11.
11. Luban N. Transfusion therapy in infants and children. Baltimore: The Johns Hopkins University Press; 1991.
12. Donowitz L, Turner R, Searcy M, et al. The high rate of blood donor exposure for critically ill infants. Infect Control Hosp Epidemiol 1989; 10:509-10.
13. Blank J, Sheagren T, Vajaria J, et al. The role of RBC transfusion in the premature neonate. Am J Dis Child 1984;138:831-3.
14. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr 1995;126:421-6.
15. Shannon K, Keith J, Mentzer W, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
16. Maier R, Obladen M, Scigalla P, et al. The effect of epoetin beta on the need for transfusion in very-low-birth weight infants. N Engl J Med 1994;330:1173-228.
17. Rhondeau SM, Christensen RD, Ross MP, et al. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with "anemia of prematurity." J Pediatr 1988;112:935-40.
18. Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo controlled pilot study. J Pediatr 1991;118:949-55.
19. Ohls R, Christensen R. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991;119:781-8.
20. Messer J, Haddad J, Donato L, et al. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92: 519-23.
21. Meyer M, Meyer J, Commerford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-23.
22. Wilimas J, Crist W. Commentary: Erythropoietin - not yet a standard treatment for anemia of prematurity. Pediatrics 1995;95:9-10.
23. Patten E, Robbins M, Vincent J, et al. Use of red blood cells older than five days for neonatal transfusion. J Perinatol 1991;11:37-40.
24. Wiley J, Koepke J. Changes in serum potassium in premature infants receiving packed red blood cells. Clin Lab Haematol 1985;7:27-31.
25. Beutler E, Wood L. The in vivo regeneration of red cell 2,3 diphosphoglyceric acid (DPG) after transfusion of stored blood. J Lab Clin Med 1969;74:300-4.
26. Brown M, Phipps R, Dallman P. Postnatal changes in fetal hemoglobin, oxygen affinity and 2,3 diphosphoglycerate in previously transfused preterm infants. Biol Neonate 1985;48:70-6.
27. Shireman T, Hilsenrath P, Strauss R, et al. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. Arch Pediatr Adolesc Med 1994;148:582-8.